Please assess the completion status of the following clinical trial:

Trial Title: IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject must be greater than or equal to 18 years of age.~2. Subject must be able and willing to sign a written informed consent document.~3. Subject requiring image-guided external beam radiotherapy to abdominal or pelvic tumor with cone beam CT deemed clinically necessary by the treating physician.~4. No history of prior allergic reaction to intravenous CT contrast medium.~5. Creatinine of less than 1.9 mg/dL measured within one month prior to enrollment on the study.~6. No administration of intravenous contrast within 24 hours of administration of intravenous contrast on protocol.~7. Ability to complete New York Presbyterian Hospital iodinated contrast media administration questionnaire.~8. Negative pregnancy test for females of childbearing potential, in accordance to institutional guidelines.~9. Ability to fast for at least 2 hours prior to study procedures.~10. Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-3.~Exclusion Criteria:~1. Known allergy to iohexol or any iodinated intravenous contrast medium.~2. Fluid overload that would contraindicate bolus administration of intravenous contrast.~3. Pregnant or nursing subjects.~4. Presence of single kidney or transplanted kidney~5. Acute renal failure~6. Chronic renal insufficiency, stage IV or V.~7. Administration of iodinated intravenous CT contrast medium within 24 hours of study procedures.~8. Inability to fast for at least 2 hours prior to study procedures.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Contrast Enhanced Cone Beam CT (Type: EXPERIMENTAL): 60 seconds after the start of the administration of IV contrast, cone beam CT will be initiated.

Based on this trial design, predict the completion outcome and termination type (if applicable).